Top Markets
#1 Brevis Brevis +37.75%
#2 Talus Network Talus Network +30.27%
#3 Tung Tung Tung Sahur Tung Tung Tung Sahur +30.12%
#4 Keep Network Keep Network +29.03%
#5 MemeCore MemeCore +24.60%
#6 Infinity Ground Infinity Ground +22.76%
#7 Allora Allora +20.35%
#8 Starpower Starpower +20.08%
#9 Synapse Synapse +18.93%
#10 屎壳郎 (Dung Beetle) 屎壳郎 (Dung Beetle) +18.73%
Coin of the day
Brevis Brevis
設定
言語
日本
通貨
USD
テーマ
IntegraGen SA IntegraGen SA

IntegraGen SA

ALINT
株式のランク #19673
IntegraGen SA provides human genome analysis services for academic researcher... IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
株価
$0.20342561
時価総額
$1.34M
変化（1日）
-1.44%
変化（1年）
-65.74%
国
FR
取引 IntegraGen SA (ALINT)

カテゴリー

Healthcare
IntegraGen SA（ALINT）の発行済株式数
December 2025 時点の発行済株式数 6.87M
IntegraGen SA の最新の財務報告および株価によると、現在の発行済株式数は 6.87M です。December 2023 の終わりには、同社は 6.61M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
IntegraGen SA（ALINT）の発行済株式数の履歴（2008 ～ 2026）
各年末時点の発行済株式数
年 発行済株式数 変化
2026 (TTM) 6.87M 1.95%
2024 6.74M 1.87%
2023 6.61M -0.22%
2022 6.63M 0.14%
2021 6.62M -0.41%
2020 6.65M 2.44%
2019 6.49M 0.35%
2018 6.46M -0.27%
2017 6.48M 29.14%
2016 5.02M -0.17%
2015 5.03M 1.70%
2014 4.94M 20.14%
2013 4.12M 0.00%
2012 4.12M 9.12%
2011 3.77M 0.00%
2010 3.77M 26.93%
2009 2.97M 0.00%
2008 2.97M 0.00%
類似企業や競合他社の発行済株式数
企業 発行済株式数 差 国
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.44B 64,584.67%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 254.10M 3,599.77%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 104.00M 1,414.27%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M 2,666.41%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 61.42M 794.28%
NL